Literature DB >> 17173062

Functional implication of BMP4 expression on angiogenesis in malignant melanoma.

T Rothhammer1, F Bataille, T Spruss, G Eissner, A-K Bosserhoff.   

Abstract

Analyses of malignant melanomas revealed a strong expression of bone morphogenic proteins (BMPs) and their autocrine effect in promoting cell invasion and migration. Here, we report a paracrine effect of BMPs on the vascular network. Both BMP2 and BMP4 induced tube formation as well as the migratory efficiency of microvascular endothelial cells. Melanoma cells with reduced BMP activity attracted less endothelial cells in invasion assays than control cells. Furthermore, reduction of BMPs in melanoma cells had a strong effect on vasculogenic mimicry. Tube formation on matrigel was analysed for melanoma cells as well as in co-cultures of endothelial and melanoma cells. Melanoma cells with reduced BMP activity were not capable of forming cord-like structures by themselves and additionally inhibited tube formation of the endothelial cells. Genes involved in angiogenesis turned out to be strongly downregulated in these cell clones. Tumors derived from cells with impaired BMP activity showed reduced tumor growth or large necrotic areas owing to lack of angiogenesis in in vivo analyses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17173062     DOI: 10.1038/sj.onc.1210182

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  68 in total

1.  Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer.

Authors:  Dan Guo; Jiayi Huang; Jianping Gong
Journal:  Mol Cell Biochem       Date:  2011-12-14       Impact factor: 3.396

Review 2.  Bone Morphogenetic Protein functions as a context-dependent angiogenic cue in vertebrates.

Authors:  David M Wiley; Suk-Won Jin
Journal:  Semin Cell Dev Biol       Date:  2011-10-12       Impact factor: 7.727

Review 3.  Stem cells and targeted approaches to melanoma cure.

Authors:  George F Murphy; Brian J Wilson; Sasha D Girouard; Natasha Y Frank; Markus H Frank
Journal:  Mol Aspects Med       Date:  2013-10-19

4.  Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice.

Authors:  Yanli Song; Laura Coleman; Jianru Shi; Hideyuki Beppu; Kaori Sato; Kenneth Walsh; Joseph Loscalzo; Ying-Yi Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-13       Impact factor: 4.733

5.  Loss of Estrogen-Related Receptor Alpha Facilitates Angiogenesis in Endothelial Cells.

Authors:  Neah Likhite; Vikas Yadav; Eric J Milliman; Danesh H Sopariwala; Sabina Lorca; Nithya P Narayana; Megha Sheth; Erin L Reineke; Vincent Giguère; Vihang Narkar
Journal:  Mol Cell Biol       Date:  2019-02-15       Impact factor: 4.272

Review 6.  Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.

Authors:  Pawina Jiramongkolchai; Philip Owens; Charles C Hong
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

Review 7.  The therapeutic promise of the cancer stem cell concept.

Authors:  Natasha Y Frank; Tobias Schatton; Markus H Frank
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

8.  Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2.

Authors:  Kelly J Gordon; Kellye C Kirkbride; Tam How; Gerard C Blobe
Journal:  Carcinogenesis       Date:  2008-12-04       Impact factor: 4.944

9.  Skeletal muscle phenotypically converts and selectively inhibits metastatic cells in mice.

Authors:  Ara Parlakian; Iman Gomaa; Sounkary Solly; Ludovic Arandel; Alka Mahale; Gustav Born; Giovanna Marazzi; David Sassoon
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

Review 10.  Tumour vascularization: sprouting angiogenesis and beyond.

Authors:  Femke Hillen; Arjan W Griffioen
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.